This Article Full Text Full Text (PDF) All Versions of this Article: 146/3/1066    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tynan, S. Articles by Allan, G. Search for Related Content PubMed PubMed Citation Articles by Tynan, S. Articles by Allan, G.

The Putative Tumor Suppressor Deleted in Malignant Brain Tumors 1 Is an Estrogen-Regulated Gene in Rodent and Primate Endometrial Epithelium

Reproductive Therapeutics (S.T., E.P., D.H.-J., J.-Z.G., S.L., G.A.), Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, New Jersey 08869; and Target Validation Team (D.L., M.R.D.), Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477

Address all correspondence and requests for reprints to: George Allan, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Room B-115, 1000 US Route 202 South, P.O. Box 300, Raritan, New Jersey 08869. E-mail: gallan{at}prdus.jnj.com.

Deleted in malignant brain tumors 1 (DMBT1) is a candidate suppressor of malignancies of the brain, lung, gut, and breast. We have been studying gene expression in the uterus in the presence of estrogens and their antagonists. Here, we show that DMBT1 RNA levels are robustly increased by estrogen treatment in the uteri of ovariectomized monkeys and rats. In monkeys, the progestin antagonist mifepristone inhibits estrogen-dependent uterine proliferation. As determined by a microarray experiment and quantitative analysis of RNA levels, mifepristone inhibited estrogenic induction of DMBT1. DMBT1 was not expressed in intact monkeys that were treated with a gonadotropin agonist to suppress steroidogenesis. An in vitro transfection study with human DMBT1 promoter constructs showed that an Alu site approximately 3000 nucleotides upstream of the gene mediates estrogenic regulation. Surprisingly, the estrogen antagonists tamoxifen, raloxifene, and ICI 182,780 also induced gene expression via this Alu site. Rodents represent a more convenient model system for studying uterine biology than monkeys. In rats, uterine DMBT1 RNA levels were dramatically up-regulated by estrogen. Consistent with the transfection study, tamoxifen and raloxifene increased DMBT1 RNA levels in vivo, but ICI 182,780 inhibited an estrogen-induced increase. Immunohistochemical studies showed that DMBT1 is specifically induced in glandular and luminal epithelia of the rat endometrium. Our experiments establish that DMBT1 is an estrogen-responsive gene with a possible role in endometrial proliferation or differentiation, and they have implications for the putative tumor suppressive and mucosal protective functions of DMBT1 in the uterus.

This article has been cited by other articles:

				G. Goudet, S. Mugnier, I. Callebaut, and P. Monget Phylogenetic Analysis and Identification of Pseudogenes Reveal a Progressive Loss of Zona Pellucida Genes During Evolution of Vertebrates Biol Reprod, May 1, 2008; 78(5): 796 - 806. [Abstract] [Full Text] [PDF]

				J.A. Horcajadas, A. Pellicer, and C. Simon Wide genomic analysis of human endometrial receptivity: new times, new opportunities Hum. Reprod. Update, January 1, 2007; 13(1): 77 - 86. [Abstract] [Full Text] [PDF]

				R. Sherwin, R. Catalano, and A. Sharkey Large-scale gene expression studies of the endometrium: what have we learnt? Reproduction, July 1, 2006; 132(1): 1 - 10. [Abstract] [Full Text] [PDF]

				C. A White and L. A Salamonsen A guide to issues in microarray analysis: application to endometrial biology Reproduction, July 1, 2005; 130(1): 1 - 13. [Abstract] [Full Text] [PDF]